New Delhi: In a pivotal step toward accessible, affordable, and technology-driven healthcare, the Technology Development Board (TDB), Department of Science and Technology, Government of India, has partnered with Primary Healthtech Pvt. Ltd. to develop and scale up an IoT-enabled AI-powered Point-of-Care Blood Testing Device. The agreement, announced on August 18, 2025, underlines the government’s commitment to advancing Indian innovation for underserved populations.
About Mobilab: Innovating Primary Healthcare Diagnostics
Founded by Mr. Sahil Jagnani and Mr. Ankit Choudhury—alumni of IIT Guwahati—Primary Healthtech Pvt. Ltd. was built by a multidisciplinary team of doctors, researchers, entrepreneurs, professors, and students. Their flagship product, Mobilab, is a portable, battery-operated clinical chemistry analyzer, integrating IoT and AI/ML algorithms. Mobilab can test over 25 essential parameters including kidney, liver, heart, vitamin, and cancer markers—offering lab-quality diagnostics at the patient’s location.
-
Patent Portfolio: The company holds a core patent for “A transmittance-based system/kit for point-of-care quantification” (transferred from IIT Guwahati), and six additional patent applications for innovations in mixers, assay development, centrifuges, and proprietary optical systems.
-
Performance and Licensing: Mobilab has undergone clinical trials on 10,000 patients and was recently granted a CDSCO manufacturing license, marking a critical milestone for commercial deployment.
Project Aims: Next-Generation Mobilab
TDB’s support will enable the upgrade of the current M1 prototype, with a focus on:
-
Performing five tests simultaneously—drastically reducing patient wait times.
-
Commercial-scale manufacturing for wider deployment.
-
Addition of critical tests—including Hemoglobin, Creatinine, Bilirubin, Cholesterol, Triglycerides, Uric Acid, Glucose, and GGT.
This next-generation device aims to provide rapid, accurate, multi-parameter diagnostics in rural and underserved regions, addressing the healthcare gap at its roots.
Leadership Perspectives
TDB Secretary, Sh. Rajesh Kumar Pathak, underscored:
“Ensuring quality healthcare access in rural and remote regions is a national priority. This project addresses affordability and accessibility, demonstrating India’s capability in indigenous, AI-powered diagnostic solutions for primary healthcare.”
The company’s founders highlighted:
“TDB’s support will accelerate our journey from lab innovation to large-scale deployment. With Mobilab, we envision bridging the healthcare gap for rural and underserved communities, ensuring advanced diagnostics are available at the point of care—anywhere in India.”
Impact and National Context
-
Atmanirbhar Bharat: The Mobilab project aligns with India’s vision of self-reliant healthcare technologies, reducing dependence on imports and promoting local innovation.
-
Global Ambition: Positioned to make Indian diagnostic solutions available on the global stage, the initiative emphasizes cost-effective, AI-driven medical advancements.
-
Digital Healthcare Transformation: By enabling digital, real-time, and point-of-care blood testing, Mobilab transforms rural health centers, clinics, and outreach programs through smarter, faster, and more efficient diagnostics.
Conclusion
The collaboration between TDB and Primary Healthtech Pvt. Ltd. marks a significant move in democratizing healthcare innovation for India’s villages and towns. With advanced AI-powered diagnostics, real-world trial validation, strong intellectual property, and government backing, Mobilab stands at the frontier of India’s mission for affordable, accessible, and indigenous healthcare solutions.
For more real-time updates, visit Channel 6 Network.
Source: PIB
